By: Sandy Kotiah, Aman Chauhan, Namrata Vijayvergia, Ryan Haumschild, William K. Oh
Explore evolving biomarker testing for rare neuroendocrine carcinomas—NGS, MSI/TMB, and emerging DLL3 targets guiding new trials.


Aman Chauhan is an Analyst at various esteemed publications including India Fantasy, Electric Vehicle Info, and Sportskeeda. With a focus on medicine and healthcare, Aman covers critical topics such as oncology, endocrinology, immunotherapy, and palliative care, contributing to a deeper understanding of diagnostics and treatment advancements. His work has been featured in notable outlets like the Journal of Sustainable Tourism, MDPI, and OncLive.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Aman Chauhan's coverage is exclusively focused on event coverage within the realm of sports, specifically cricket and the T20 World Cup 2024. If you have insights or commentary related to specific cricket matches, player performance analyses, pitch conditions, or Dream11 predictions for ongoing tournaments, he would likely be receptive to your pitches.
Given his focus on match-specific content such as player battles and pitch reports, Aman may particularly appreciate expert analysis that adds depth and context to individual matchups during the T20 World Cup 2024.
This information evolves through artificial intelligence and human feedback. Improve this profile .